ZIM Laboratories inks pact with Globalpharma to commercialize oral thin film products

09 Apr 2025 Evaluate

ZIM Laboratories has entered into a dossier license, product supply, and technology know-how license agreement with Globalpharma Co (L.L.C.). This partnership encompasses dossier licensing, bulk product supply, and the licensing of the company’s proprietary oral thin film technology platform, ThinOral. 

Under the agreement, Globalpharma will register and commercialize 10 OTF-based Pharmaceutical and Nutraceutical products developed by the company, catering to regional patient needs with advanced, user-friendly dosage forms. Initially, the company will supply bulk products while providing complete regulatory support for market registration in the UAE. Post-approval, the company will deliver ready-to-use powder mixes, enabling Globalpharma to undertake localized manufacturing and marketing of the finished formulations.

The partnership marks a pivotal milestone in ZIM Labs’ mission to make differentiated formulations globally accessible and reinforces its presence in the rapidly growing Middle Eastern Pharmaceutical market.

ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.


Zim Laboratories Share Price

70.68 -0.47 (-0.66%)
05-Dec-2025 15:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1520.55
Zydus Lifesciences 933.10
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×